Qube Research & Technologies (QRT)
KZR

Qube Research & Technologies (QRT)’s Kezar Life Sciences KZR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,395
Closed -$34K – 3671
2024
Q3 		$34K Sell
4,395
-11,263
-72% -$67.9K ﹤0.01% 2914
2024
Q2 		$94K Buy
+15,658
New +$119K ﹤0.01% 2616
2024
Q1 		– Sell
-19
Closed -$184 – 4693
2023
Q4 		$184 Buy
+19
New +$167 ﹤0.01% 3980
2023
Q1 		– Sell
-2,195
Closed -$155K – 2815
2022
Q4 		$155K Buy
+2,195
New +$163K ﹤0.01% 1888
2022
Q2 		– Sell
-1,005
Closed -$167K – 2854
2022
Q1 		$167K Buy
+1,005
New +$144K ﹤0.01% 1990
2020
Q4 		– Sell
-1,570
Closed -$76K – 2026
2020
Q3 		$76K Buy
+1,570
New +$75.1K ﹤0.01% 1515

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KZR Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 4,395 shares — an estimated $34K sold.

Qube Research & Technologies (QRT) first reported a position in KZR in Q3 2020 and held it in 6 quarters. The position peaked at $167K in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 4,395 Kezar Life Sciences shares in Q4 2024, an estimated $34K.
  • Qube Research & Technologies (QRT) first reported a position in Kezar Life Sciences in Q3 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Kezar Life Sciences position peaked at $167K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.